Anhydrous silver dihydrogen citrate compositions

Details Anhydrous silver dihydrogen citrate compositions Anhydrous silver dihydrogen citrate compositions

2007-03-27

2010-06-08

Sheikh, Humera N (Department: 1615)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heavy metal containing doai

Reexamination Certificate

active

07732486

ABSTRACT:
Anhydrous silver dihydrogen citrate compositions comprise silver dihydrogen citrate and citric acid. The anhydrous compositions can be prepared by freeze-drying. The anhydrous compositions can be reconstituted with a suitable diluent to form silver dihydrogen citrate compositions. The anhydrous compositions can be reconstituted and applied to a variety of substrates to impart an antimicrobial effect on the substrates.

REFERENCES:
patent: 2658072 (1953-11-01), Kosmin
patent: 3303090 (1967-02-01), Huffman et al.
patent: 3422183 (1969-01-01), Ellison
patent: 3600186 (1971-08-01), Mattson
patent: 3647439 (1972-03-01), Bass
patent: 3702298 (1972-11-01), Zsoldos
patent: 3929678 (1975-12-01), Laughlin et al.
patent: 4005195 (1977-01-01), Jandacek et al.
patent: 4005196 (1977-01-01), Jandacek et al.
patent: 4021578 (1977-05-01), Harich et al.
patent: 4055655 (1977-10-01), Maurer et al.
patent: 4104190 (1978-08-01), Hartshorn
patent: 4180473 (1979-12-01), Muarer et al.
patent: 4264592 (1981-04-01), Xhajanka
patent: 4291125 (1981-09-01), Greatbatch
patent: 4297374 (1981-10-01), Wess
patent: 4385632 (1983-05-01), Odelhog
patent: 4564461 (1986-01-01), Skold et al.
patent: 4608183 (1986-08-01), Rossmoore
patent: 4666616 (1987-05-01), Rossmoore
patent: 4708808 (1987-11-01), Rossmoore
patent: 4753821 (1988-06-01), Giesecke et al.
patent: 4755268 (1988-07-01), Matsuo et al.
patent: 4780216 (1988-10-01), Wojtowicz
patent: 4797300 (1989-01-01), Jandacek et al.
patent: 4889844 (1989-12-01), Silvetti, Sr. et al.
patent: 4908355 (1990-03-01), Gettings et al.
patent: 4915955 (1990-04-01), Gomori
patent: 4933178 (1990-06-01), Capelli
patent: 5011681 (1991-04-01), Ciotti et al.
patent: 5017295 (1991-05-01), Antelman
patent: 5063062 (1991-11-01), Greenspan et al.
patent: 5073382 (1991-12-01), Antelman
patent: 5078902 (1992-01-01), Antelman
patent: 5081106 (1992-01-01), Bentley et al.
patent: 5089275 (1992-02-01), Antelman
patent: 5177065 (1993-01-01), Silvetti, Sr. et al.
patent: 5236698 (1993-08-01), Richard et al.
patent: 5306514 (1994-04-01), Letton
patent: 5306515 (1994-04-01), Letton
patent: 5306516 (1994-04-01), Letton
patent: 5332511 (1994-07-01), Gay et al.
patent: 5332568 (1994-07-01), Raspanti
patent: 5338539 (1994-08-01), Raspanti
patent: 5362714 (1994-11-01), Radford et al.
patent: 5364649 (1994-11-01), Rossmoore et al.
patent: 5373025 (1994-12-01), Gay
patent: 5382337 (1995-01-01), Wlassics et al.
patent: 5464559 (1995-11-01), Marchin et al.
patent: 5503840 (1996-04-01), Jacobson et al.
patent: 5510109 (1996-04-01), Tomioka et al.
patent: 5518713 (1996-05-01), Raspanti
patent: 5520906 (1996-05-01), Stein et al.
patent: 5601811 (1997-02-01), Gallagher et al.
patent: 5660840 (1997-08-01), Pruett
patent: 5736591 (1998-04-01), Dunn
patent: 5820918 (1998-10-01), Ronan et al.
patent: 5962517 (1999-10-01), Murad
patent: 6017461 (2000-01-01), Garvey et al.
patent: 6139823 (2000-10-01), Dreschsler et al.
patent: 6181963 (2001-01-01), Chin et al.
patent: 6197814 (2001-03-01), Arata
patent: 6294186 (2001-09-01), Beerse et al.
patent: 6387355 (2002-05-01), Heidenfelder et al.
patent: 6409995 (2002-06-01), Habeck et al.
patent: 6478946 (2002-11-01), Westwood
patent: 6583176 (2003-06-01), Arata
patent: 6605751 (2003-08-01), Gibbins et al.
patent: 6692773 (2004-02-01), Burrell et al.
patent: 6838095 (2005-01-01), Newman et al.
patent: 6843784 (2005-01-01), Modak et al.
patent: 6890953 (2005-05-01), Arata
patent: 7026308 (2006-04-01), Gavin et al.
patent: 7261905 (2007-08-01), Arata
patent: 2002/0016349 (2002-02-01), Heywang et al.
patent: 2002/0192298 (2002-12-01), Burrell et al.
patent: 2003/0198689 (2003-10-01), Arata
patent: 2004/0044073 (2004-03-01), Arata
patent: 2005/0202066 (2005-09-01), Arata
patent: 2005/0245605 (2005-11-01), Arata
patent: 2005/0247643 (2005-11-01), Arata
patent: 2005/0274624 (2005-12-01), Arata
patent: 2006/0051430 (2006-03-01), Arata et al.
patent: 2006/0100273 (2006-05-01), Arata
patent: 2006/0115440 (2006-06-01), Arata et al.
patent: 2006/0188584 (2006-08-01), Arata
patent: 2007/0269530 (2007-11-01), Arata
patent: 0507691 (1992-10-01), None
patent: 0517104 (1992-12-01), None
patent: 0570838 (1993-11-01), None
patent: 0582189 (1994-02-01), None
patent: 0613893 (1994-09-01), None
patent: 0709080 (1996-05-01), None
patent: 1046391 (2000-10-01), None
patent: 1133980 (2001-09-01), None
patent: 1167358 (2002-01-01), None
patent: 1270410 (1972-04-01), None
patent: 2236117 (1991-03-01), None
patent: 47-32537 (1972-08-01), None
patent: 4-330007 (1992-11-01), None
patent: WO 93/17002 (1993-09-01), None
patent: WO 96/28390 (1996-09-01), None
patent: WO 97/00851 (1997-01-01), None
patent: WO 99/18790 (1999-04-01), None
patent: WO 00/27390 (2000-05-01), None
patent: WO 2005/020915 (2005-03-01), None
patent: WO 2005/041861 (2005-05-01), None
patent: WO 2006/029213 (2006-03-01), None
Thomas Van Auken; “Solubility and Heat of Solution of Potassium dihydrogen citrate”, J. Chem. Eng., 1991 36, p. 255-257.
Baxter S, “Evaluation of Axen® for Residual Activity,”Nelson Laboratories, Inc., Salt Lake City, Utah, 1-22 (Feb. 8, 2002).
Derwent Abstract, Accession No. 2000-268443, abstracting RU 2125971 (Feb. 10, 1999).
Derwent Abstract, Accession No. 2002-265533, abstracting RU 2179155 (Feb. 10, 2002).
IMS, “Axen® 30, Disinfectant, Fungicide & Virucide,”Manufactured by ETI H20, a Division of Innovative Medical Services, El Cajon, CA.
IMS, “IMS Announces Positive Research Results of Anti-Bacterial Acne Ingredient,” Press Release,Innovative Medical Services, El Cajon, Feb. 12, 2002.
Kawana R et al., “Inactivation of Human Viruses by Povidone-Iodine in Comparison with Other Antiseptics,”Dermatology, 195(2):29-35 (1997).
Lin YE, Stout JE, Yu VL, “Experimental Results: Efficacy of Axenohol Solution in EradicatingLegionella pneumophilal,” Special Pathogens Laboratory, VA Pittsburgh Healthcare System, Pittsburgh, PA 15240.
Mayer JL, “Accelerated Storage Stability of Axenohol and Axen,”EPL Bio-Analytical Services, Inc., Harristown, Illinois, 1-48 (May 8, 2000).
Miller JW, “Storage Stability of Axenohl and Axen Under Warehouse Conditions,”EPL Bio-Analytical Services, Inc., Harristown, Illinois 1-71 (Aug. 10, 2001).
Moore GE, “Acute Dermal Toxicity Study in Rats—Limit Test,”product safety labs, East Brunswick, New Jersey, 1-14, (Oct. 21, 1999).
Moore GE, “Acute Oral Toxicity Study in Rats—Limit Test,”product safety labs, East Brunswick, New Jersey, 1-14, (Oct. 21, 1999).
Moore GE, “Dermal Sensitization Study in Guinea Pigs (Buehler Method),”product safety labs, East Brunswick, New Jersey, 1-24, (Oct. 21, 1999).
Moore GE, “Primary Eye Irritation Study in Rabbits,”product safety labs, East Brunswick, New Jersey, 1-1.5, (Oct. 6, 1999).
Moore GE, “Primary Eye Irritation Study in Rabbits,”product safety labs, East Brunswick, New Jersey, 1-15, (Oct. 21, 1999).
Moore GE, “Primary Skin Irritation Study in Rabbits,”product safety labs, East Brunswick, New Jersey, 1-15, (Oct. 21, 1999).
NLM, “PubChem Substance Summary” (PubChem Substance ID 679028) for “silver citrate,” from theNational Center for Biotechnology Informationat the National Library of Medicine.
Product No. 006976, description of commercially available “silver citrate”, from the online catalogue ofCrescent Chemical Company, located at 1324 Motor Parkway, Islandia, New York 11749.
Product No. 3222, “silver nitrate” from the online catalogue ofProChem, Inc., located at 826 Roosevelt Road, Rockford, IL 61109.
Richli P, Swiss 446691 (CLA 24b), “Preservatives for Tobacco,”Chemical Abstracts 69.8964n, (Mar. 15, 1968, Appl. Apr. 22, 1964).
Srivastava GC et al., “Development of ready to use antiseptic dressings—Part 1. . . ”Labdev J. Scr. Tech., vol. 8-B (4):209-213, (Oct. 1970).
Tsimbler SM, Novikova LS (USSR), “Complexes of Silver (1) with some

Affiliated with

Also associated with

Rating

Anhydrous silver dihydrogen citrate compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Anhydrous silver dihydrogen citrate compositions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anhydrous silver dihydrogen citrate compositions will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4245921